Chinese General Practice ›› 2021, Vol. 24 ›› Issue (36): 4607-4611.DOI: 10.12114/j.issn.1007-9572.2021.02.060
Special Issue: 骨质疏松最新文章合集; 神经退行性病变最新文章合集; 帕金森最新文章合集; 营养最新文章合集
• Monographic Research • Previous Articles Next Articles
Published:
2021-12-20
Online:
2021-12-24
基金资助:
XU Xiaohui, TIAN Junmei, CAI Weiwei, ZHAO Yongfei, WANG Yupeng, LIU Chao, DUAN Zhihui. Sex-specific Correlations of Fracture Risk with Nutritional Status,Body Composition and Balance Condition in Parkinson's Disease Patients [J]. Chinese General Practice, 2021, 24(36): 4607-4611.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.060
一般资料 | 女(n=31) | 男(n=37) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄〔M(P25,P75),岁〕 | 68.0(64.0,72.0) | 71.0(65.0,74.0) | 0.855a | 0.395 | |
独居〔n(%)〕 | 0.442b | 0.506 | |||
是 | 7(22.6) | 6(16.2) | |||
否 | 24(77.4) | 31(83.8) | |||
骨折史〔n(%)〕 | 0.112b | 0.738 | |||
有 | 2(6.5) | 2(5.4) | |||
无 | 29(93.5) | 35(94.6) | |||
剂末现象〔n(%)〕 | 0.061b | 0.805 | |||
有 | 4(12.9) | 3(8.1) | |||
无 | 27(87.1) | 34(91.9) | |||
步态冻结现象〔n(%)〕 | 0.352b | 0.553 | |||
有 | 1(3.2) | 1(2.7) | |||
无 | 30(96.8) | 36(97.3) | |||
开关现象〔n(%)〕 | 0.352b | 0.553 | |||
有 | 1(3.2) | 1(2.7) | |||
无 | 30(96.8) | 36(97.3) | |||
未来10年MOF风险〔M(P25,P75),%〕 | 0.89(0.48,2.20) | 0.34(0.12,1.54) | 0.747 | 0.457 | |
未来10年HF风险(±s,%) | 1.76±0.53 | 1.65±0.81 | 0.657 | 0.514 | |
股骨颈骨密度T值(±s,g/cm2) | -1.24±1.38 | -0.47±1.51 | 2.192 | 0.032 | |
UPDRS Ⅲ评分(±s,分) | 35.6±9.6 | 29.1±14.9 | 2.086 | 0.041 | |
MNA评分(±s,分) | 23.2±3.2 | 24.6±3.8 | 1.604 | 0.114 | |
BFR(±s,%) | 31.7±8.6 | 24.9±6.2 | 3.771 | <0.001 | |
BMI(±s,kg/m2) | 24.2±3.0 | 23.5±2.5 | 0.996 | 0.323 | |
三头肌皮褶厚度(±s,mm) | 16.4±5.0 | 12.2±5.2 | 3.385 | 0.001 | |
AC(±s,cm) | 30.0±13.0 | 28.1±2.7 | 0.875 | 0.385 | |
WHR(±s,%) | 0.89±0.06 | 0.88±0.07 | 0.862 | 0.392 | |
躯干肌肉量(±s,kg) | 18.28±2.16 | 22.35±3.21 | 5.991 | <0.001 | |
双上肢肌肉量(±s,kg) | 4.35±1.27 | 5.48±1.01 | 4.087 | <0.001 | |
双下肢肌肉量(±s,kg) | 10.84±1.85 | 14.07±2.76 | 5.543 | <0.001 | |
BBS评分(±s,分) | 2.5±1.0 | 3.0±1.0 | 2.055 | 0.044 | |
ABC评分(±s,分) | 59.7±17.2 | 66.3±20.6 | 1.416 | 0.161 |
Table 1 Comparison of general characteristics of PD patients by sex
一般资料 | 女(n=31) | 男(n=37) | 检验统计量值 | P值 | |
---|---|---|---|---|---|
年龄〔M(P25,P75),岁〕 | 68.0(64.0,72.0) | 71.0(65.0,74.0) | 0.855a | 0.395 | |
独居〔n(%)〕 | 0.442b | 0.506 | |||
是 | 7(22.6) | 6(16.2) | |||
否 | 24(77.4) | 31(83.8) | |||
骨折史〔n(%)〕 | 0.112b | 0.738 | |||
有 | 2(6.5) | 2(5.4) | |||
无 | 29(93.5) | 35(94.6) | |||
剂末现象〔n(%)〕 | 0.061b | 0.805 | |||
有 | 4(12.9) | 3(8.1) | |||
无 | 27(87.1) | 34(91.9) | |||
步态冻结现象〔n(%)〕 | 0.352b | 0.553 | |||
有 | 1(3.2) | 1(2.7) | |||
无 | 30(96.8) | 36(97.3) | |||
开关现象〔n(%)〕 | 0.352b | 0.553 | |||
有 | 1(3.2) | 1(2.7) | |||
无 | 30(96.8) | 36(97.3) | |||
未来10年MOF风险〔M(P25,P75),%〕 | 0.89(0.48,2.20) | 0.34(0.12,1.54) | 0.747 | 0.457 | |
未来10年HF风险(±s,%) | 1.76±0.53 | 1.65±0.81 | 0.657 | 0.514 | |
股骨颈骨密度T值(±s,g/cm2) | -1.24±1.38 | -0.47±1.51 | 2.192 | 0.032 | |
UPDRS Ⅲ评分(±s,分) | 35.6±9.6 | 29.1±14.9 | 2.086 | 0.041 | |
MNA评分(±s,分) | 23.2±3.2 | 24.6±3.8 | 1.604 | 0.114 | |
BFR(±s,%) | 31.7±8.6 | 24.9±6.2 | 3.771 | <0.001 | |
BMI(±s,kg/m2) | 24.2±3.0 | 23.5±2.5 | 0.996 | 0.323 | |
三头肌皮褶厚度(±s,mm) | 16.4±5.0 | 12.2±5.2 | 3.385 | 0.001 | |
AC(±s,cm) | 30.0±13.0 | 28.1±2.7 | 0.875 | 0.385 | |
WHR(±s,%) | 0.89±0.06 | 0.88±0.07 | 0.862 | 0.392 | |
躯干肌肉量(±s,kg) | 18.28±2.16 | 22.35±3.21 | 5.991 | <0.001 | |
双上肢肌肉量(±s,kg) | 4.35±1.27 | 5.48±1.01 | 4.087 | <0.001 | |
双下肢肌肉量(±s,kg) | 10.84±1.85 | 14.07±2.76 | 5.543 | <0.001 | |
BBS评分(±s,分) | 2.5±1.0 | 3.0±1.0 | 2.055 | 0.044 | |
ABC评分(±s,分) | 59.7±17.2 | 66.3±20.6 | 1.416 | 0.161 |
指标 | 男性 | 女性 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
未来10年MOF风险 | 未来10年HF风险 | 股骨颈骨密度T值 | 未来10年MOF风险 | 未来10年HF风险 | 股骨颈骨密度T值 | |||||||
r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | |
年龄 | 0.270a | 0.106 | 0.285a | 0.088 | -0.284a | 0.088 | 0.363a | 0.045 | 0.096a | 0.606 | -0.359a | 0.048 |
UPDRSⅢ评分 | 0.544 | <0.001 | 0.460 | 0.004 | 0.163 | 0.589 | 0.768 | <0.001 | 0.684 | <0.001 | 0.193 | 0.432 |
MNA评分 | -0.652 | <0.001 | -0.546 | <0.001 | 0.131 | 0.701 | -0.482 | 0.006 | -0.501 | 0.004 | 0.182 | 0.520 |
BFR | 0.055 | 0.710 | 0.087 | 0.521 | -0.535 | 0.001 | -0.013 | 0.947 | -0.016 | 0.930 | 0.060 | 0.750 |
BMI | 0.245 | 0.144 | 0.052 | 0.760 | -0.183 | 0.278 | -0.228 | 0.217 | -0.205 | 0.269 | 0.020 | 0.915 |
三头肌皮褶厚度 | 0.128 | 0.452 | -0.043 | 0.802 | -0.134 | 0.430 | -0.058 | 0.758 | 0.022 | 0.905 | -0.048 | 0.798 |
AC | 0.121 | 0.135 | 0.160 | 0.128 | -0.356 | 0.051 | -0.094 | 0.614 | 0.081 | 0.665 | -0.129 | 0.489 |
WHR | 0.194 | 0.249 | 0.086 | 0.611 | -0.120 | 0.478 | 0.312 | 0.087 | 0.004 | 0.985 | -0.394 | 0.028 |
躯干肌肉量 | -0.147 | 0.384 | -0.107 | 0.528 | 0.251 | 0.134 | -0.173 | 0.351 | -0.189 | 0.310 | -0.099 | 0.597 |
双上肢肌肉量 | -0.190 | 0.259 | -0.139 | 0.411 | 0.239 | 0.155 | -0.073 | 0.698 | -0.385 | 0.032 | 0.119 | 0.523 |
双下肢肌肉量 | -0.648 | <0.001 | -0.553 | <0.001 | 0.621 | <0.001 | -0.572 | 0.001 | -0.638 | <0.001 | 0.436 | 0.014 |
BBS评分 | -0.610 | <0.001 | -0.553 | <0.001 | 0.142 | 0.676 | -0.403 | 0.024 | -0.485 | 0.006 | 0.337 | 0.063 |
ABC评分 | -0.708 | <0.001 | -0.642 | <0.001 | 0.144 | 0.672 | -0.800 | <0.001 | -0.718 | <0.001 | 0.146 | 0.653 |
Table 2 Correlation analysis of fracture risk and T-score of femoral neck bone mineral density with other indicators in PD patients by sex
指标 | 男性 | 女性 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
未来10年MOF风险 | 未来10年HF风险 | 股骨颈骨密度T值 | 未来10年MOF风险 | 未来10年HF风险 | 股骨颈骨密度T值 | |||||||
r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | r(rs)值 | P值 | |
年龄 | 0.270a | 0.106 | 0.285a | 0.088 | -0.284a | 0.088 | 0.363a | 0.045 | 0.096a | 0.606 | -0.359a | 0.048 |
UPDRSⅢ评分 | 0.544 | <0.001 | 0.460 | 0.004 | 0.163 | 0.589 | 0.768 | <0.001 | 0.684 | <0.001 | 0.193 | 0.432 |
MNA评分 | -0.652 | <0.001 | -0.546 | <0.001 | 0.131 | 0.701 | -0.482 | 0.006 | -0.501 | 0.004 | 0.182 | 0.520 |
BFR | 0.055 | 0.710 | 0.087 | 0.521 | -0.535 | 0.001 | -0.013 | 0.947 | -0.016 | 0.930 | 0.060 | 0.750 |
BMI | 0.245 | 0.144 | 0.052 | 0.760 | -0.183 | 0.278 | -0.228 | 0.217 | -0.205 | 0.269 | 0.020 | 0.915 |
三头肌皮褶厚度 | 0.128 | 0.452 | -0.043 | 0.802 | -0.134 | 0.430 | -0.058 | 0.758 | 0.022 | 0.905 | -0.048 | 0.798 |
AC | 0.121 | 0.135 | 0.160 | 0.128 | -0.356 | 0.051 | -0.094 | 0.614 | 0.081 | 0.665 | -0.129 | 0.489 |
WHR | 0.194 | 0.249 | 0.086 | 0.611 | -0.120 | 0.478 | 0.312 | 0.087 | 0.004 | 0.985 | -0.394 | 0.028 |
躯干肌肉量 | -0.147 | 0.384 | -0.107 | 0.528 | 0.251 | 0.134 | -0.173 | 0.351 | -0.189 | 0.310 | -0.099 | 0.597 |
双上肢肌肉量 | -0.190 | 0.259 | -0.139 | 0.411 | 0.239 | 0.155 | -0.073 | 0.698 | -0.385 | 0.032 | 0.119 | 0.523 |
双下肢肌肉量 | -0.648 | <0.001 | -0.553 | <0.001 | 0.621 | <0.001 | -0.572 | 0.001 | -0.638 | <0.001 | 0.436 | 0.014 |
BBS评分 | -0.610 | <0.001 | -0.553 | <0.001 | 0.142 | 0.676 | -0.403 | 0.024 | -0.485 | 0.006 | 0.337 | 0.063 |
ABC评分 | -0.708 | <0.001 | -0.642 | <0.001 | 0.144 | 0.672 | -0.800 | <0.001 | -0.718 | <0.001 | 0.146 | 0.653 |
指标 | 未来10年MOF风险 | 未来10年HF风险 | ||
---|---|---|---|---|
r值 | P值 | r值 | P值 | |
UPDRS Ⅲ评分 | 0.252 | 0.043 | 0.186 | 0.139 |
MNA评分 | -0.245 | 0.049 | -0.222 | 0.045 |
BFR | 0.038 | 0.547 | 0.041 | 0.435 |
BMI | -0.040 | 0.749 | -0.136 | 0.280 |
三头肌皮褶厚度 | -0.020 | 0.875 | -0.110 | 0.382 |
AC | 0.027 | 0.830 | -0.215 | 0.085 |
WHR | 0.046 | 0.713 | 0.223 | 0.075 |
躯干肌肉量 | -0.073 | 0.561 | -0.060 | 0.638 |
双上肢肌肉量 | -0.009 | 0.944 | -0.150 | 0.234 |
双下肢肌肉量 | -0.376 | 0.002 | -0.344 | 0.005 |
BBS评分 | -0.245 | 0.049 | -0.288 | 0.020 |
ABC评分 | -0.402 | 0.001 | -0.358 | 0.003 |
Table 3 Partial correlation analysis of fracture risk with other indicators after controlling for gender,age and T-score of femoral neck bone mineral density in PD patients
指标 | 未来10年MOF风险 | 未来10年HF风险 | ||
---|---|---|---|---|
r值 | P值 | r值 | P值 | |
UPDRS Ⅲ评分 | 0.252 | 0.043 | 0.186 | 0.139 |
MNA评分 | -0.245 | 0.049 | -0.222 | 0.045 |
BFR | 0.038 | 0.547 | 0.041 | 0.435 |
BMI | -0.040 | 0.749 | -0.136 | 0.280 |
三头肌皮褶厚度 | -0.020 | 0.875 | -0.110 | 0.382 |
AC | 0.027 | 0.830 | -0.215 | 0.085 |
WHR | 0.046 | 0.713 | 0.223 | 0.075 |
躯干肌肉量 | -0.073 | 0.561 | -0.060 | 0.638 |
双上肢肌肉量 | -0.009 | 0.944 | -0.150 | 0.234 |
双下肢肌肉量 | -0.376 | 0.002 | -0.344 | 0.005 |
BBS评分 | -0.245 | 0.049 | -0.288 | 0.020 |
ABC评分 | -0.402 | 0.001 | -0.358 | 0.003 |
[1] | SHEARD J M, ASH S, SILBURN P A,et al.Prevalence of malnutrition in Parkinson's disease:a systematic review[J].Nutr Rev,2011,69(9):520-532.DOI:10.1111/j.1753-4887.2011.00413.x. |
[2] | 洪维,朱晓颖,程群,等.老年髋部骨折患者肌肉减少症与骨密度的关系[J].中华骨质疏松和骨矿盐疾病杂志,2014,7(2):106-112. |
[3] | WANG J, WANG X J, FANG Z,et al.The effect of FRAX on the prediction of osteoporotic fractures in urban middle-aged and elderly healthy Chinese adults[J].Clinics (Sao Paulo),2017,72(5):289-293.DOI:10.6061/clinics/2017(05)06. |
[4] | SCOTT D, CHANDRASEKARA S D, LASLETT L L,et al.Associations of sarcopenic obesity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years in community-dwelling older adults[J].Calcif Tissue Int,2016,99(1):30-42.DOI:10.1007/s00223-016-0123-9. |
[5] | POSTUMA R B, BERG D, STERN M,et al.MDS clinical diagnostic criteria for Parkinson's disease[J].Mov Disord,2015,30(12):1591-1601.DOI:10.1002/mds.26424. |
[6] | CHEN K K, JIN Z H, GAO L,et al.Efficacy of short-term multidisciplinary intensive rehabilitation in patients with different Parkinson's disease motor subtypes:a prospective pilot study with 3-month follow-up[J].Neural Regen Res,2021,16(7):1336-1343.DOI:10.4103/1673-5374.301029. |
[7] | FERESHTEHNEJAD S M, GHAZI L, SADEGHI M,et al.Prevalence of malnutrition in patients with Parkinson's disease:a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire[J].J Parkinsons Dis,2014,4(3):473-481.DOI:10.3233/JPD-130323. |
[8] | FERRAZZOLI D, FASANO A, MAESTRI R,et al.Balance dysfunction in Parkinson's disease:the role of posturography in developing a rehabilitation program[J].Parkinsons Dis,2015,2015:520128.DOI:10.1155/2015/520128. |
[9] | SCHEPENS S, GOLDBERG A, WALLACE M.The short version of the Activities-specific Balance Confidence (ABC) scale:its validity,reliability,and relationship to balance impairment and Falls in older adults[J].Arch Gerontol Geriatr,2010,51(1):9-12.DOI:10.1016/j.archger.2009.06.003. |
[10] | MÜLLER A, MÜNGERSDORF M, REICHMANN H,et al.Olfactory function in Parkinsonian syndromes[J].J Clin Neurosci,2002,9(5):521-524.DOI:10.1054/jocn.2001.1071. |
[11] | MACIA F, PERLEMOINE C, COMAN I,et al.Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight[J].Mov Disord,2004,19(2):206-212.DOI:10.1002/mds.10630. |
[12] | ZORRILLA E P, TACHÉ Y, KOOB G F.Nibbling at CRF receptor control of feeding and gastrocolonic motility[J].Trends Pharmacol Sci,2003,24(8):421-427.DOI:10.1016/S0165-6147(03)00177-9. |
[13] | FADEL J, DEUTCH A Y.Anatomical substrates of orexin-dopamine interactions:lateral hypothalamic projections to the ventral tegmental area[J].Neuroscience,2002,111(2):379-387.DOI:10.1016/s0306-4522(02)00017-9. |
[14] | WILLS A M, LI R S, PÉREZ A,et al.Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort[J].J Neurol,2017,264(8):1746-1753.DOI:10.1007/s00415-017-8562-4. |
[15] | SCHEPENS S, GOLDBERG A, WALLACE M.The short version of the Activities-specific Balance Confidence (ABC) scale:its validity,reliability,and relationship to balance impairment and Falls in older adults[J].Arch Gerontol Geriatr,2010,51(1):9-12.DOI:10.1016/j.archger.2009.06.003. |
[16] | US Preventive Services Task Force, CURRY S J, KRIST A H,et al.Screening for osteoporosis to prevent fractures:US preventive services task force recommendation statement[J].JAMA,2018,319(24):2521-2531.DOI:10.1001/jama.2018.7498. |
[17] | ZHANG Y, HAO Q, GE M,et al.Association of sarcopenia and fractures in community-dwelling older adults:a systematic review and meta-analysis of cohort studies[J].Osteoporos Int,2018,29(6):1253-1262.DOI:10.1007/s00198-018-4429-5. |
[18] | YU R, LEUNG J, WOO J.Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men[J].J Am Med Dir Assoc,2014,15(12):918-923.DOI:10.1016/j.jamda.2014.07.011. |
[19] | COMPSTON J, COOPER A, COOPER C,et al.UK clinical guideline for the prevention and treatment of osteoporosis[J].Arch Osteoporos,2017,12(1):43.DOI:10.1007/s11657-017-0324-5. |
[20] | SZULC P, FEYT C, CHAPURLAT R.High risk of fall,poor physical function,and low grip strength in men with fracture-the STRAMBO study[J].J Cachexia Sarcopenia Muscle,2016,7(3):299-311.DOI:10.1002/jcsm.12066. |
[21] | VAN DER MARCK M A, DICKE H C, UC E Y,et al.Body mass index in Parkinson's disease:a meta-analysis[J].Parkinsonism Relat Disord,2012,18(3):263-267.DOI:10.1016/j.parkreldis.2011.10.016. |
[22] | DI MONACO M, CASTIGLIONI C, VALLERO F,et al.Sarcopenia is more prevalent in men than in women after hip fracture:a cross-sectional study of 591 inpatients[J].Arch Gerontol Geriatr,2012,55(2):e48-52.DOI:10.1016/j.archger.2012.05.002. |
[23] | VERSCHUEREN S, GIELEN E, O'NEILL T W,et al.Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men[J].Osteoporos Int,2013,24(1):87-98.DOI:10.1007/s00198-012-2057-z. |
[24] | PAHOR M, MANINI T, CESARI M.Sarcopenia:clinical evaluation,biological markers and other evaluation tools[J].J Nutr Health Aging,2009,13(8):724-728.DOI:10.1007/s12603-009-0204-9. |
[25] | WANG C, SWERDLOFF R S, IRANMANESH A,et al.Transdermal testosterone gel improves sexual function,mood,muscle strength,and body composition parameters in hypogonadal men[J].J Clin Endocrinol Metab,2000,85(8):2839-2853.DOI:10.1210/jcem.85.8.6747. |
[26] | BORST S E.Interventions for sarcopenia and muscle weakness in older people[J].Age Ageing,2004,33(6):548-555.DOI:10.1093/ageing/afh201. |
[27] | KALILANI L, ASGHARNEJAD M, PALOKANGAS T,et al.Comparing the incidence of Falls/fractures in Parkinson's disease patients in the US population[J].PLoS One,2016,11(9):e0161689.DOI:10.1371/journal.pone.0161689. |
[1] | XUE Shan, LI Laiyou, LIANG Junli, JIN Yinghui, WEI Shuyan. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2540-2547. |
[2] | WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161. |
[3] | ZHANG Yutong, WANG Qiuqin, XU Yuchen, WENG Heng, LIANG Yongqi, WANG Lulu, WANG Qing, XU Guihua. Factors Affecting Pain in Patients with Parkinson's Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(14): 1766-1774. |
[4] | LIU Yanhui, CHEN Shuchun. Interpretation and Clinical Significance of the Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement [J]. Chinese General Practice, 2023, 26(12): 1422-1428. |
[5] | DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng. Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease [J]. Chinese General Practice, 2023, 26(12): 1450-1455,1471. |
[6] | WANG Ruobing, WANG Liugen, LI Heping, ZENG Xi. Analysis of Influencing Factors of the Nutritional Status in Stoke Patients Hospitalized at Different Time Points [J]. Chinese General Practice, 2023, 26(06): 665-671. |
[7] | CHEN Ying, ZHENG Hui, HE Yu. Association between Nutritional Status and Prognosis in Elderly Patients with Heart Failure with Preserved Ejection Fraction and Coronary Heart Diseases [J]. Chinese General Practice, 2023, 26(03): 335-342. |
[8] | YANG Chen, HE Huajuan, LI Jianpu, CHEN Jun. Prevalence and Influencing Factors of Sarcopenia in Essential Hypertension [J]. Chinese General Practice, 2022, 25(35): 4381-4388. |
[9] | MU Lisha, GONG Tao, XU Huini, CHEN Dan, TANG Jie, CAI Shuwen, MU Lihong. Effects of a Chinese-style DASH Diet on Nutritional Health in Hypertensive Patients with Type 2 Diabetes [J]. Chinese General Practice, 2022, 25(34): 4304-4311. |
[10] | Hui ZHOU, Chenjie LING, Shengli XUE, Jing YANG. Body Composition Analysis during Allogeneic Hematopoietic Stem Cell Transplantation in Overweight/Obese Patients with Hematologic Diseases [J]. Chinese General Practice, 2022, 25(30): 3755-3760. |
[11] | Yanrong MENG, Limin LIU. Predictive Value of Preoperative Controlling Nutritional Status Score for 1-year Postoperative Mortality in Elderly Patients with Hip Fracture [J]. Chinese General Practice, 2022, 25(23): 2874-2880. |
[12] | Gen HUANG, Huimin CAO, Gang YU. Novel Developments in Hypomimia in Parkinson's Disease [J]. Chinese General Practice, 2022, 25(20): 2558-2562. |
[13] | Jianhua XIE, Miaomiao LIU, Lili PENG, Rongsan ZHANG, Hongzhen ZHANG. Systemic Immune-inflammatory-nutritional Index and Survival in Elderly NSCLC Patients with Non-surgical Treatment [J]. Chinese General Practice, 2022, 25(17): 2082-2089. |
[14] |
SHI Xiaoxue, ZHENG Jinhua, MA Jianjun, WANG Zhidong, SUN Wenhua, LI Mingjian, HUANG Shen, HU Shiyu, LI Dongsheng.
Risk Factors of Dysphagia in Parkinson's Disease [J]. Chinese General Practice, 2022, 25(06): 669-674. |
[15] | YANG Xu. Differences in Clinical Characteristics when REM Sleep Behavior Disorder Precedes or Comes after the Onset of Parkinson's Disease [J]. Chinese General Practice, 2021, 24(8): 959-963. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||